Study of the impact of the IL-7R on non-small cell lung cancer / Pedro Lino Rosado ; orient. João Barata... [et al.]
Main Author Rosado, Pedro Lino Secondary Author Barata, João Pedro TabordaFragoso, Ana Rita
Serpa, Jacinta Language Inglês. Country Portugal. Publication Lisboa : NOVA Medical School, Universidade NOVA de Lisboa, 2023 Description 86 p. Dissertation Note or Thesis: Dissertação de Mestrado
Investigação Biomédica
2023
Faculdade de Ciências Médicas, Universidade NOVA de Lisboa
Abstract Abstract Lung cancer, a complex and multifaceted disease, is the second most common malignancy and the leading cause of cancer related deaths worldwide. Non-small cell lung cancer (NSCLC) comprises most lung cancer cases, and, despite advances in diagnostic and therapeutic regimens, it remains a global health burden mainly due to diagnosis at advanced stages and treatment resistance. Interleukin-7 (IL-7) and thymic stromal lymphopoietin (TSLP) are cytokines that due to their roles in regulating immune responses and tumour-promoting functions have been gathering attention and been studied in the context of tumorigenesis. IL-7 plays a pivotal role in the proliferation and differentiation of immune players including T-cells and B-cells. In addition to its role in lymphopoiesis, IL-7 is closely related with tumorigenesis reportedly increasing the viability and proliferation of several tumours, haematological and non-haematological, including NSCLC. TSLP, recognized for its role in allergies and lung inflammation, has recently emerged as a significant mediator of tumorigenesis, either dependently or independently of type 2 immune responses. Nevertheless, a clear role of IL-7 or TSLP in NSCLC remains to be established. The work presented and discussed herein sought to clarify the role of the IL-7, and TSLP signalling axis in NSCLC. We found that NSCLC cells can express the IL-7Rα, the TSLPR, and both IL-7 and TSLP, at different extents. By stimulating with IL-7, we observed no activation of the signalling pathway nor changes in survival, likely due to the absence of expression of the gamma chain observed, which is necessary for IL-7-mediated signalling. On the contrary, TSLP stimulation led to the activation of its corresponding signalling pathway in NSCLC cell line H1975. Importantly, we observed several mechanisms by which TSLP might promote tumorigenesis. TSLP stimulation impacted lung cancer cell migration and invasion, and augmented cell viability. Overall, our work suggests that TSLP may play an important role in NSCLC development and progression and its inhibition may have a therapeutic value. As for IL-7 no relevant link was found, but further studies need to be performed to dissect its tumorigenic potential in the context of lung cancer Topical name Carcinoma, Non-Small-Cell Lung
Interleukin-7
Thymic Stromal Lymphopoietin
Survival
Emigration and Immigration
Academic Dissertation Online Resources Click here to access the eletronic resource http://hdl.handle.net/10362/162289
| Item type | Current location | Call number | url | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Documento Eletrónico | Biblioteca NMS|FCM online | RUN | http://hdl.handle.net/10362/162289 | Available | 20240028 |
Dissertação de Mestrado Investigação Biomédica 2023 Faculdade de Ciências Médicas, Universidade NOVA de Lisboa
Abstract Lung cancer, a complex and multifaceted disease, is the second most common malignancy and the leading cause of cancer related deaths worldwide. Non-small cell lung cancer (NSCLC) comprises most lung cancer cases, and, despite advances in diagnostic and therapeutic regimens, it remains a global health burden mainly due to diagnosis at advanced stages and treatment resistance. Interleukin-7 (IL-7) and thymic stromal lymphopoietin (TSLP) are cytokines that due to their roles in regulating immune responses and tumour-promoting functions have been gathering attention and been studied in the context of tumorigenesis. IL-7 plays a pivotal role in the proliferation and differentiation of immune players including T-cells and B-cells. In addition to its role in lymphopoiesis, IL-7 is closely related with tumorigenesis reportedly increasing the viability and proliferation of several tumours, haematological and non-haematological, including NSCLC. TSLP, recognized for its role in allergies and lung inflammation, has recently emerged as a significant mediator of tumorigenesis, either dependently or independently of type 2 immune responses. Nevertheless, a clear role of IL-7 or TSLP in NSCLC remains to be established. The work presented and discussed herein sought to clarify the role of the IL-7, and TSLP signalling axis in NSCLC. We found that NSCLC cells can express the IL-7Rα, the TSLPR, and both IL-7 and TSLP, at different extents. By stimulating with IL-7, we observed no activation of the signalling pathway nor changes in survival, likely due to the absence of expression of the gamma chain observed, which is necessary for IL-7-mediated signalling. On the contrary, TSLP stimulation led to the activation of its corresponding signalling pathway in NSCLC cell line H1975. Importantly, we observed several mechanisms by which TSLP might promote tumorigenesis. TSLP stimulation impacted lung cancer cell migration and invasion, and augmented cell viability. Overall, our work suggests that TSLP may play an important role in NSCLC development and progression and its inhibition may have a therapeutic value. As for IL-7 no relevant link was found, but further studies need to be performed to dissect its tumorigenic potential in the context of lung cancer
Click on an image to view it in the image viewer
There are no comments for this item.